You need to login...
If you are not registered...
| Subscribe to Krixos Health: | |
|
or call us on: +43 (0)1 27 63 015 or email: subscribe@krixos.com |
|
Most viewed
- 1. NuCana to Present Data on NUC-7738's Synergy with PD-1 Inhibitors at the ESMO Congress 2025
- 2. Case report: Curative effect and mechanism of surufatinib combined with toripalimab in the treatment of 1 case of lung large-cell neuroendocrine carcinoma
- 3. Study identifies key features of cancer cell response and resistance to treatment
- 4. Molecular test personalises prostate cancer treatment
- 5. Potential application of nanodelivery systems targeting ELAVL1 in prostate cancer treatment
- 6. Case Report: Genomic insights into prostate adenocarcinoma transdifferentiation to carcinosarcoma due to lineage plasticity
- 7. Challenges and breakthroughs: current landscape and future prospects of CAR-T cell therapy clinical trials for solid tumors
- 8. "This Is How We Do It" Star Montell Jordan Opens Up About His Prostate Cancer Journey As Part of Powerful New Partnership with ZERO Prostate Cancer
- 9. Deep learning in breast cancer risk prediction: a review of recent applications in full-field digital mammography
- 10. Key parameters in intratumoral-peritumoral region fusion models: optimizing deep learning radiomics for breast cancer diagnosis
Last updated at 14:43 GMT
Hot News Makers
Health/Pharma Companies
-
59673.29
-
50782.39
-
14065.47
-
11765.87
-
10919.36
-
10187.82
-
10040.67
-
8719.68
-
4682.53
-
4567.22
Drugs, Treatments, Trials
-
6170.05
-
5452.07
-
4649.84
-
4641.46
-
3799.25
-
3170.59
-
3094.31
-
2615.09
-
2432.40
-
2276.78
Last updated at 14:10 GMT
